Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,247.8
-35.6 (-1.08%)

 

  • STI Straits Times Index
    3,247.8
    -35.6 (-1.08%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,505.6
    -16.3 (-1.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,243.6
    -412.8 (-1.67%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,433.1
    -91.0 (-2.58%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,283.7M
  • Value: 1,512.0M
  • Rise: 68
  • Fall: 276
  • Unch: 423

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
DISA0.007-0.001
Jiutian Chemical0.084-0.001
Stamford Land R0.003-
YZJ Shipbldg SGD1.260-0.060
Singtel2.470-0.020
Shen Yao0.003-
Genting Sing0.740-0.020
Sembcorp Marine0.083-
Mapletree NAC Tr1.100+0.010
Keppel DC Reit2.190-0.060

World Indices

World Indices
Name Last Change
Nasdaq 13,855.1 +86.2
HSI 24,243.6 -412.9
HSCEI 8,503.4 -154.8
Jakarta 6,568.2 -87.0
Nikkei 225 27,131.3 -457.0
SSE Comp 3,433.1 -91.0
Shanghai A 3,597.7 -95.5
Shanghai B 279.5 -5.7
KOSPI 2,720.4 -71.6

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MEDAVAIL HOLDINGS INC MEDAVAIL HOLDINGS INC
Updated on 24 Jan 2022 (End of trading day)
Last (USD): 1.410 Change: +0.020 High: 1.430 Remarks: -
Change (%): +1.44 Low: 1.280
Open 1.360 Yesterday's Close 1.39
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 200,222 Cumulative Value

Company Background

MedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company was founded on April 11, 2007 and is headquartered in Mississauga, Canada.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.81618 Trailing EPS (USD) b -1.31739 NAV (USD) c 0.9504
PE a - Trailing PE d - Price / NAV c 1.4836
Dividend Yield (%) e - Cash In Hand (USD) f 1.1043 Issued & Paid-up Shares g 32,848,200
Piotroski F Score 3 Market Cap (M) 46.316 Free Float (%) 78.1
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i 1,110.384
Net Earnings Growth (%) j -1,089.173 Net Debt/Equity k Net Cash
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 15 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.050
-3.42 %
10 Days -+0.160
+12.80 %
20 Days -+0.080
+6.02 %
Medium Term Return 3 Months --1.240
-46.79 %
6 Months --7.510
-84.19 %
1 Year --12.490
-89.86 %
Annualised Return Annualised --
-89.86 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MEDAVAIL HOLDINGS INC NASDAQ 46.316 - - 1.4836 -
Industry Medical Specialties NASDAQ 2,591.751 148.227 191.346 8.8316 0.030
Local Peer INTUITIVE SURGICAL INC NASDAQ 97,089.245 - - - -
Local Peer IDEXX LABORATORIES INC NASDAQ 43,384.645 74.573 57.322 57.4817 -
Local Peer DEXCOM INC NASDAQ 41,369.217 83.811 78.158 19.3667 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 37,410.276 21.066 50.551 10.6377 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 22,436.296 30.836 48.643 6.7632 -
Local Peer HOLOGIC INC NASDAQ 17,814.870 9.519 9.519 4.2229 -
Local Peer INSULET CORPORATION NASDAQ 15,379.708 2,261.663 - 30.8890 -
Local Peer ABIOMED INC NASDAQ 14,192.490 62.931 95.155 10.2505 -
Local Peer MASIMO CORPORATION NASDAQ 12,342.602 51.363 53.188 8.4069 -
Local Peer DENTSPLY SIRONA INC NASDAQ 11,778.545 - 28.212 2.2996 0.743
Local Peer BRUKER CORPORATION NASDAQ 10,253.395 64.977 37.933 9.5327 0.237
Local Peer TANDEM DIABETES CARE INC NASDAQ 7,956.200 - 365.668 20.4187 -
Other Local Peers NOVOCURE LTD (NASDAQ), SOTERA HEALTH CO (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), QUIDEL CORP (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), LIVANOVA PLC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), INMODE LTD (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), ATRICURE INC (NASDAQ), LUMIRADX LTD (NASDAQ), AXONICS INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), CAREDX INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), HESKA CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), VERICEL CORP (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), CUE HEALTH INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ATRION CORP (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), BIOVENTUS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), CERUS CORP (NASDAQ), PULMONX CORPORATION (NASDAQ), ANGIODYNAMICS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), VIEWRAY INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), AIRSCULPT TECHNOLOGIES INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), INOGEN INC (NASDAQ), SI BONE INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), INTERCURE LTD (NASDAQ), CUTERA INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), NYXOAH SA (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), IRADIMED CORP (NASDAQ), 908 DEVICES INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), DERMTECH INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), AXOGEN INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZYNEX INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), NEUROPACE INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), LUCIRA HEALTH INC (NASDAQ), EARGO INC (NASDAQ), CVRX INC (NASDAQ), TELA BIO INC (NASDAQ), CORMEDIX INC (NASDAQ), TALIS BIOMEDICAL CORP<